Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia [1]

European Journal of Haematology

Volumn 73, Issue 1, 2004, Pages 71-72

  Meyer, Oliver ^a   Kiesewetter, Holger ^a   Hermsen, Manfred ^b   Salama, Abdulgabar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY; RHOPHYLAC;

CHILL; CLINICAL TRIAL; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEVER; HEADACHE; HEMOLYSIS; HUMAN; LETTER; NAUSEA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RHO(D) IMMUNE GLOBULIN;

EID: 3042564147     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00244.x     Document Type: Letter

References (9)

1. BLANCHETTE V, IMBACH P, ANDREW M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-707.
2. SCARADAVOU A, WOO B, WOLOSKI BM, CUNNINGHAM-RUNDLES S, ETTINGER LJ, ALEDORT LM, BUSSEL JB. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997;89:2689-2700.
3. VESELY SK, BUCHANAN GR, ADIX L, GEORGE JN, COHEN AR, BLANCHETTE VS, KUHNE T. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003;25:130-133.
4. GAINES AR. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombo-cytopenic purpura patients. Blood 2000;95:2523-2529.
5. SALAMA A, KIEFEL V, MUELLER-ECKHARDT C. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 1986;22:241-250.
6. GRINGERI A, CATTANEO M, SANTAGOSTINO E, MANNUCCI PM. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura. Br J Haematol 1992;80:337-340.
7. BORGNA-PIGNATTI C, BATTISTI L, ZECCA M, LOCATELLI F. Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins. Br J Haematol 1994;88:618-620.
8. SMITH GN, GRIFFITHS B, MOLLISON D, MOLLISON PL. Uptake of IgG after intramuscular and subcutaneous injection. Lancet 1972;1:1208-1212.
9. GARDULF A, ANDERSEN V, BJORKANDER J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 1995;345:365-369.